KR900001371A - 상승효과를 가지는 약학적 조성물 및 그 제조방법 - Google Patents

상승효과를 가지는 약학적 조성물 및 그 제조방법 Download PDF

Info

Publication number
KR900001371A
KR900001371A KR1019880008503A KR880008503A KR900001371A KR 900001371 A KR900001371 A KR 900001371A KR 1019880008503 A KR1019880008503 A KR 1019880008503A KR 880008503 A KR880008503 A KR 880008503A KR 900001371 A KR900001371 A KR 900001371A
Authority
KR
South Korea
Prior art keywords
preparation
pharmaceutical compositions
pharmaceutical composition
synergistic effect
piperacillin
Prior art date
Application number
KR1019880008503A
Other languages
English (en)
Other versions
KR900006980B1 (ko
Inventor
김영설
Original Assignee
김영설
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1019880008503A priority Critical patent/KR900006980B1/ko
Application filed by 김영설 filed Critical 김영설
Priority to EP89112354A priority patent/EP0362490B1/en
Priority to ES89112354T priority patent/ES2063079T3/es
Priority to DE68914569T priority patent/DE68914569T2/de
Priority to AU37916/89A priority patent/AU633834B2/en
Priority to CA000605069A priority patent/CA1336412C/en
Priority to JP1174045A priority patent/JPH0791189B2/ja
Priority to CN89104648A priority patent/CN1055390C/zh
Priority to KR1019890013841A priority patent/KR900006981B1/ko
Publication of KR900001371A publication Critical patent/KR900001371A/ko
Application granted granted Critical
Publication of KR900006980B1 publication Critical patent/KR900006980B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

상승효과를 가지는 약학적 조성물 및 그 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 설박탐을 피페라실린 또는 메탐피실린과 혼합하여 상승적으로 그 향균효과가 증강된 약학적 조성물.
  2. 제 1항에 있어서, 약학적 조성물을 주사제의 제조에 통상으로 사용되는 부형제, 희석제, 안정제 및 주사용 증류수와 통상의 주사제, 제조방법에 따라 제조한 주사제.
  3. 제 1항에서 약학적 조성물을 정제나 캡슐제에 통상으로 사용되는 부형제, 희석제, 안정제, 활택제와 함께 통상의 정제 또는 캡슐제 제조방법에 따라서 제조된 경구용 약학적 제제.
  4. 제 1항에서 설박캄과 피페라실린 또는 메탐피실란을 1 : 99 내지 99 : 1의 비율로 혼합한 약학적 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880008503A 1988-07-08 1988-07-08 상승효과를 가지는 약학적 조성물 KR900006980B1 (ko)

Priority Applications (9)

Application Number Priority Date Filing Date Title
KR1019880008503A KR900006980B1 (ko) 1988-07-08 1988-07-08 상승효과를 가지는 약학적 조성물
ES89112354T ES2063079T3 (es) 1988-07-08 1989-07-06 Una composicion farmaceutica que tiene efecto sinergico basada en sulbactam y metampicilina.
DE68914569T DE68914569T2 (de) 1988-07-08 1989-07-06 Pharmazeutische Zusammensetzung mit synergistischer Wirkung auf der Basis von Sulbactam und Methampicillin.
AU37916/89A AU633834B2 (en) 1988-07-08 1989-07-06 A pharmaceutical composition having synergistic effect
EP89112354A EP0362490B1 (en) 1988-07-08 1989-07-06 A pharmaceutical composition having synergistic effect based on sulbactam and methampicillin
CA000605069A CA1336412C (en) 1988-07-08 1989-07-07 Pharmaceutical composition having synergistic effect
JP1174045A JPH0791189B2 (ja) 1988-07-08 1989-07-07 抗菌用組成物
CN89104648A CN1055390C (zh) 1988-07-08 1989-07-08 具有协同作用的药物组合物的制备方法
KR1019890013841A KR900006981B1 (ko) 1988-07-08 1989-09-26 상승효과를 가지는 약학적 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019880008503A KR900006980B1 (ko) 1988-07-08 1988-07-08 상승효과를 가지는 약학적 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019890013841A Division KR900006981B1 (ko) 1988-07-08 1989-09-26 상승효과를 가지는 약학적 조성물

Publications (2)

Publication Number Publication Date
KR900001371A true KR900001371A (ko) 1990-02-27
KR900006980B1 KR900006980B1 (ko) 1990-09-25

Family

ID=19275944

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019880008503A KR900006980B1 (ko) 1988-07-08 1988-07-08 상승효과를 가지는 약학적 조성물
KR1019890013841A KR900006981B1 (ko) 1988-07-08 1989-09-26 상승효과를 가지는 약학적 조성물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019890013841A KR900006981B1 (ko) 1988-07-08 1989-09-26 상승효과를 가지는 약학적 조성물

Country Status (8)

Country Link
EP (1) EP0362490B1 (ko)
JP (1) JPH0791189B2 (ko)
KR (2) KR900006980B1 (ko)
CN (1) CN1055390C (ko)
AU (1) AU633834B2 (ko)
CA (1) CA1336412C (ko)
DE (1) DE68914569T2 (ko)
ES (1) ES2063079T3 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0606506A1 (en) * 1993-01-12 1994-07-20 Yeong Sul Kim Beta-lactamase resistant antibacterial composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056160B2 (ja) * 1977-06-07 1985-12-09 フアイザ−・インコ−ポレ−テツド β−ラクタマ−ゼ阻害剤としてのペニシラン酸１，１−ジオキシド
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
US5049384A (en) * 1988-07-08 1991-09-17 Kim Young S Antibacterial composition for medical use and a process for the preparation thereof

Also Published As

Publication number Publication date
AU633834B2 (en) 1993-02-11
EP0362490A2 (en) 1990-04-11
DE68914569T2 (de) 1994-08-25
KR900006981B1 (ko) 1990-09-25
AU3791689A (en) 1990-03-08
EP0362490B1 (en) 1994-04-13
JPH0791189B2 (ja) 1995-10-04
CN1039357A (zh) 1990-02-07
ES2063079T3 (es) 1995-01-01
KR900006980B1 (ko) 1990-09-25
EP0362490A3 (en) 1990-09-05
DE68914569D1 (de) 1994-05-19
KR900002681A (ko) 1990-02-28
CN1055390C (zh) 2000-08-16
CA1336412C (en) 1995-07-25
JPH02104528A (ja) 1990-04-17

Similar Documents

Publication Publication Date Title
KR970020098A (ko) 항스트레스 조성물
EA200000718A1 (ru) Композиции целекоксиба
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
KR900005978A (ko) 키니딘, 아르테미시닌 및 이의 유도체를 사용한 항말라리아 조성물 및 치료방법
BR9811137A (pt) Processo para redução de hiperglicemia e processo para redução de hiperglicemia e estabilização do nìvel de glicose sérica, composição farmacêutica, e, uso de tripicolinato crÈmico sintético
KR920017669A (ko) 갈륨 화합물
FR2455892A1 (fr) Composition pharmaceutique comprenant un extrait du contenu de glande a venin d'abeille
KR900001371A (ko) 상승효과를 가지는 약학적 조성물 및 그 제조방법
KR920017668A (ko) 암 전이 억제 또는 예방 방법 및 이를 위한 제제
KR920021144A (ko) 역류성 식도염을 치료하기위한 니자티딘의 용도
KR940701249A (ko) 진통제
RU93058633A (ru) Противоядие, способ его получения, фармацевтическая композиция, способ противодействия яду и комплект
ES2123005T3 (es) Composicion farmaceutica que contiene carbacol y otras sustancias colinergicas.
SE8902607D0 (sv) Oxaza heterocycles and pharmaceutical compositions containing same
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
KR910002447A (ko) 상승효과를 가지는 약학적 조성물 및 그 제조방법
KR910002792A (ko) 1-치환된-2-(3-아미노-1-프로피닐)피롤리딘 유도체, 그에 의한 중추 콜린성 기능 장해 치료 방법 및 그로구성되는 제약학적 조성물
KR930001907A (ko) 페니실린계 약학적 조성물 및 그 제조방법
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
KR870011135A (ko) 시스-6-(4-아세트아닐리도)-8,9-디메톡시-2-메틸-1,2,3,4,4a,10b- 헥사이드로-벤조〔c〕〔1,6〕 나프티리딘으로 구성된 약학적 조성물 및 그것의 용도
KR920016021A (ko) 동물의 발육 촉진 또는 개선 사료 및 방법
KR940006465A (ko) 주사제용 보존제
DE68901656T2 (de) Pharmazeutische zusammensetzung zur milderung der nebenwirkungen von platinhaltigen arzneimitteln.
KR900017599A (ko) 종양 치료용 약학 조성물
KR850005270A (ko) 찜질용 조성물

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060926

Year of fee payment: 17

LAPS Lapse due to unpaid annual fee